Crossmark

Caution!! Reappearance of remimazolam effect after a flumazenil bolus: a larger bolus of flumazenil and a lower total remimazolam clearance are higher risks

Crossref DOI link: https://doi.org/10.1007/s00540-022-03107-x

Published Online: 2022-09-16

Published Print: 2023-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Masui, Kenichi https://orcid.org/0000-0003-4702-9874
License Information

Text and Data Mining valid from 2022-09-16

Version of Record valid from 2022-09-16
More Information

Article History

Received: 21 August 2022

Accepted: 7 September 2022

First Online: 16 September 2022

Declarations

:

: Kenichi Masui was a consultant/advisor for Mundipharma K.K., Tokyo, Japan, and had been awarded a research grant for another study and received payment for delivering domestic lectures from Mundipharma. Additionally, he is an Editor of Journal of Anesthesia, and an Editorial Board of JA Clinical Reports.

Free to read: This content has been made available to all.

Document is current

Any future updates will be listed below